Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults

J Clin Pharmacol. 2006 Oct;46(10):1204-11. doi: 10.1177/0091270006291838.

Abstract

The population pharmacokinetics of desmopressin in children with nocturnal enuresis and in healthy adults were compared using a 1-compartment model with first-order absorption and first-order elimination. In addition, the model consisted of a number of transit compartments before absorption to describe a lag-time. The model gave an adequate description of adult as well as children data and provided a statistically significant better fit to data than a standard lag-time model. The main difference in the pharmacokinetics between children and adults was the absorption delay. The pharmacokinetic difference was minor and presumably of no clinical relevance.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Sublingual
  • Adolescent
  • Adult
  • Age Factors
  • Algorithms
  • Antidiuretic Agents / administration & dosage
  • Antidiuretic Agents / pharmacokinetics*
  • Antidiuretic Agents / therapeutic use
  • Biological Availability
  • Child
  • Cross-Over Studies
  • Deamino Arginine Vasopressin / administration & dosage
  • Deamino Arginine Vasopressin / pharmacokinetics*
  • Deamino Arginine Vasopressin / therapeutic use
  • Dosage Forms
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Freeze Drying
  • Humans
  • Intestinal Absorption
  • Metabolic Clearance Rate
  • Middle Aged
  • Models, Biological
  • Nocturnal Enuresis / drug therapy*
  • Nocturnal Enuresis / metabolism
  • Tissue Distribution

Substances

  • Antidiuretic Agents
  • Dosage Forms
  • Deamino Arginine Vasopressin